Regeneron Pharmaceuticals (REGN)

Change in Working Capital

-$161.10M

Quarterly · Period ending: · USD

REGN logo

REGN Change in Working Capital

Latest reported-$161.10M
REGN Quarterly Change in Working Capital (-$1.40M → -$161.10M)
High-resolution chart · PNG

REGN change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
3,603,000
2,079,000
1,985,000
-3,246,000
-2,527,000
-11,466,000
5,500,000
-4,600,000
1,600,000
-1,300,000
-1,800,000
4,100,000
-7,700,000
-2,000,000
1,000,000
-1,400,000
-1,700,000
-500,000
2,600,000
-3,900,000
-3,400,000
-3,800,000
3,400,000
-9,200,000
-2,400,000
-6,600,000
-8,500,000
-5,300,000
12,300,000
-1,500,000
-400,000
1,300,000
900,000
1,300,000
-200,000
1,300,000
-200,000
600,000
1,300,000
-1,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.